BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18161531)

  • 21. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.
    Resende DM; Caetano BC; Dutra MS; Penido ML; Abrantes CF; Verly RM; Resende JM; Piló-Veloso D; Rezende SA; Bruna-Romero O; Fernandes AP; Gazzinelli RT
    Vaccine; 2008 Aug; 26(35):4585-93. PubMed ID: 18588933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating antigen-specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay.
    Ewen CL; Rong J; Kokaji AI; Bleackley RC; Kane KP
    J Immunol Methods; 2006 Jan; 308(1-2):156-66. PubMed ID: 16375915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses.
    Baz A; Buttigieg K; Zeng W; Rizkalla M; Jackson DC; Groves P; Kelso A
    Vaccine; 2008 May; 26(21):2570-9. PubMed ID: 18420312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor.
    Ge L; Zhang JG; Samathanam CA; Delgado C; Tarbiyat-Boldaji M; Dan Q; Hoa N; Nguyen TV; Alipanah R; Pham JT; Sanchez R; Wepsic HT; Morgan TR; Jadus MR
    Cell Immunol; 2009; 259(2):117-27. PubMed ID: 19615673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of CD8+ T cell avidity by increasing the turnover of viral antigen during infection.
    Gray PM; Parks GD; Alexander-Miller MA
    Cell Immunol; 2004; 231(1-2):14-9. PubMed ID: 15919365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.
    Hofmann C; Harrer T; Kubesch V; Maurer K; Metzner KJ; Eismann K; Bergmann S; Schmitt-Haendle M; Schuler G; Dörrie J; Schaft N
    AIDS; 2008 Aug; 22(13):1577-82. PubMed ID: 18670216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular CD154 expression reflects antigen-specific CD8+ t cells but shows less sensitivity than intracellular cytokine and MHC tetramer staining.
    Han YW; Aleyas AG; George JA; Yoon HA; Lee JH; Kim BS; Eo SK
    J Microbiol Biotechnol; 2007 Dec; 17(12):1955-64. PubMed ID: 18167442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating in vivo death rates of targets due to CD8 T-cell-mediated killing.
    Ganusov VV; De Boer RJ
    J Virol; 2008 Dec; 82(23):11749-57. PubMed ID: 18815293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells.
    Oizumi S; Deyev V; Yamazaki K; Schreiber T; Strbo N; Rosenblatt J; Podack ER
    J Immunother; 2008 May; 31(4):394-401. PubMed ID: 18391756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequencies of functionally competent circulating Tax-specific CD8+ T cells in human T lymphotropic virus type 2 infection.
    Oliveira AL; Hayakawa H; Schor D; Leite AC; Espíndola OM; Waters A; Dean J; Doherty DG; Araújo AQ; Hall WW
    J Immunol; 2009 Sep; 183(5):2957-65. PubMed ID: 19657093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells.
    Zimmermann SY; Esser R; Rohrbach E; Klingebiel T; Koehl U
    J Immunol Methods; 2005 Jan; 296(1-2):63-76. PubMed ID: 15680151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells.
    Chen K; Chen L; Zhao P; Marrero L; Keoshkerian E; Ramsay A; Cui Y
    J Immunol Methods; 2005 May; 300(1-2):100-14. PubMed ID: 15899496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity.
    Narayan S; Choyce A; Fernando GJ; Leggatt GR
    Eur J Immunol; 2007 Feb; 37(2):406-15. PubMed ID: 17274003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct detection of cytolytic T lymphocyte-mediated cytotoxicity on antigen-transfected cell microarray.
    Rong J; Chris Bleackley R; Kane KP
    J Immunol Methods; 2007 Sep; 326(1-2):1-9. PubMed ID: 17673228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sorting and pooling strategy: a novel tool to map a virus proteome for CD8 T-cell epitopes.
    Ay B; Streitz M; Boisguerin P; Schlosser A; Mahrenholz CC; Schuck SD; Kern F; Volkmer R
    Biopolymers; 2007; 88(1):64-75. PubMed ID: 17117459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine flow cytometry: a multiparametric approach for assessing cellular immune responses to viral antigens.
    Maino VC; Maecker HT
    Clin Immunol; 2004 Mar; 110(3):222-31. PubMed ID: 15047200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8 cytotoxic T cells in cutaneous leishmaniasis.
    Ruiz JH; Becker I
    Parasite Immunol; 2007 Dec; 29(12):671-8. PubMed ID: 18042173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.
    Neri S; Mariani E; Meneghetti A; Cattini L; Facchini A
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1131-5. PubMed ID: 11687452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.